A detailed history of Sarissa Capital Management LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sarissa Capital Management LP holds 410,483 shares of NBIX stock, worth $50.2 Million. This represents 9.54% of its overall portfolio holdings.

Number of Shares
410,483
Previous 346,426 18.49%
Holding current value
$50.2 Million
Previous $47.8 Million 18.28%
% of portfolio
9.54%
Previous 8.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $8.38 Million - $9.17 Million
64,057 Added 18.49%
410,483 $56.5 Million
Q1 2024

May 15, 2024

SELL
$130.4 - $143.74 $16.1 Million - $17.8 Million
-123,574 Reduced 26.29%
346,426 $47.8 Million
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $11 Million - $13.8 Million
104,000 Added 28.42%
470,000 $61.9 Million
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $12.7 Million - $15.8 Million
134,700 Added 58.24%
366,000 $41.2 Million
Q2 2023

Aug 14, 2023

BUY
$89.53 - $104.87 $20.7 Million - $24.3 Million
231,300 New
231,300 $21.8 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.